Group One Trading’s Elevation Oncology ELEV Stock Holding History

Group One Trading’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	-$52	–	8083
2025 Q1	$52	Buy	+200	New	+$114	﹤0.01%	7425

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's ELEV Position: Q3 2025 in Review

Group One Trading sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 118 shares — an estimated $43 sold.

Group One Trading first reported a position in ELEV in Q3 2024 and held it in 4 quarters. The position peaked at $60 in Q3 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Group One Trading reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 118 Elevation Oncology shares in Q3 2025, an estimated $43.
Group One Trading first reported a position in Elevation Oncology in Q3 2024 and held it in 4 quarters.
Group One Trading's Elevation Oncology position peaked at $60 in Q3 2024.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.